Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer.
Eur J Med Res. 2022 Jul 2;27(1):105. doi: 10.1186/s40001-022-00730-y.
Eur J Med Res. 2022.
PMID: 35780240
Free PMC article.
Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis.
Chen X, Ma J, Xu C, Wang L, Yao Y, Wang X, Zi T, Bian C, Wu D, Wu G.
Chen X, et al.
Discov Oncol. 2022 Jun 30;13(1):54. doi: 10.1007/s12672-022-00508-y.
Discov Oncol. 2022.
PMID: 35768705
Free PMC article.
Item in Clipboard
Cite
Cite